Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Courses
Press/Media
Search by expertise, name or affiliation
Targeting Alzheimer's disease: Is there a light at the end of the tunnel?
David Gurwitz
*
*
Corresponding author for this work
Human Molecular Genetics Biochemistry
Research output
:
Contribution to journal
›
Short survey
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting Alzheimer's disease: Is there a light at the end of the tunnel?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
100%
Pharmacotherapy
33%
Drug Development
33%
Drug Target
33%
Early Diagnosis
33%
Parkinson's Disease
33%
Human Lifespan
33%
Future Health
33%
Alzheimer's Disease Treatment
33%
Current Costs
33%
Anti-Alzheimer Drugs
33%
Development Research
33%
Developed Nations
33%
Cost to Society
33%
Disease Threat
33%
At-risk Individuals
33%
Health Budget
33%
Medicine and Dentistry
Alzheimer's Disease
100%
Health Care Cost
20%
Parkinson's Disease
20%
Prevalence
20%
Lifespan
20%
Drug Therapy
20%
Combination Therapy
20%
Early Diagnosis
20%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Lifespan
100%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Prevalence
20%
Drug Development
20%
Pharmacotherapy
20%
Combination Therapy
20%
Parkinson's Disease
20%